Please use this identifier to cite or link to this item: https://doi.org/10.1007/s10120-008-0458-7
DC FieldValue
dc.titleReduction of hospital stay and cost after the implementation of a clinical pathway for radical gastrectomy for gastric cancer
dc.contributor.authorSo, J.B.Y.
dc.contributor.authorLim, Z.L.
dc.contributor.authorLin, H.-A.
dc.contributor.authorTi, T.-K.
dc.date.accessioned2016-11-11T08:00:44Z
dc.date.available2016-11-11T08:00:44Z
dc.date.issued2008-06
dc.identifier.citationSo, J.B.Y., Lim, Z.L., Lin, H.-A., Ti, T.-K. (2008-06). Reduction of hospital stay and cost after the implementation of a clinical pathway for radical gastrectomy for gastric cancer. Gastric Cancer 11 (2) : 81-85. ScholarBank@NUS Repository. https://doi.org/10.1007/s10120-008-0458-7
dc.identifier.issn14363291
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/130082
dc.description.abstractBackground. Clinical pathways have been used for various surgical procedures to improve outcomes and reduce costs. Radical gastrectomy is a major surgery for the treatment of gastric cancer. This study serves to evaluate the difference in clinical outcomes before and after patients were managed on a multidisciplinary gastrectomy pathway. Methods. Between 2000 and 2005, 115 consecutive patients who underwent gastrectomy were categorized into a prepathway group and a pathway group. This corresponded to the implementation of the clinical pathway in August 2002. The 61 patients in the pathway group were managed according to a multidisciplinary program, while the 54 patients in the pre-pathway group were managed conventionally. The clinical outcomes and hospital costs were then assessed and compared. Results. The two groups were similar in terms of demographics, comorbidities, types of gastrectomies, and pathological cancer staging. The postoperative length of hospital stay (LOS) was 9 days for the pathway group and 11 days for the pre-pathway group (P = 0.02), and the total LOS in the two groups was 11 and 14 days, respectively (P = 0.02). The cost of hospitalization for the pathway patients was S$13 338, which was significantly lower compared to the S$17 371 cost for the pre-pathway patients (P = 0.047). Conclusion. Clinical pathways may reduce hospital stay and costs for patients undergoing gastrectomy for the treatment of gastric cancer. © 2008 The International Gastric Cancer Association and The Japanese Gastric Cancer Association.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1007/s10120-008-0458-7
dc.sourceScopus
dc.subjectClinical pathway
dc.subjectGastrectomy
dc.subjectGastric cancer
dc.typeArticle
dc.contributor.departmentSURGERY
dc.description.doi10.1007/s10120-008-0458-7
dc.description.sourcetitleGastric Cancer
dc.description.volume11
dc.description.issue2
dc.description.page81-85
dc.description.codenGCANF
dc.identifier.isiut000257328300004
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.